Press Release

Thursday, 05 July 2018

System for transporting donor lungs approved in USA following trial

In a clinical trial called INSPIRE, a large international team of investigators led by physicians at Hannover Medical School (MHH) has shown that the transport and storage of donor lungs using the Organ Care System (OCS) – developed by Transmedics, Inc. – is safer and more effective than the current standard procedure, namely storage at four degrees Celsius. Another clinical benefit: patients who received an organ preserved using the OCS had a lower incidence of primary graft dysfunction (a common complication with cold storage, and which usually occurs within the first 72 hours). “The potential implications for patients are shorter ventilation periods and more rapid discharge,” says Professor Gregor Warnecke, chief physician (leitender Oberarzt) at MHH’s Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG) and the study’s principal investigator. Twenty-one transplant centres were involved in this international trial, in which MHH treated the largest patient group.

In late March, based on the study’s outcome, the United States Food and Drug Administration (USFDA) granted approval for the OCS for storage of lungs for transplantation.

Download the press release (in German):
This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree